SCHEMBL25474208

SCHEMBL25474208

CCCCOc1ccc2nccc(C(=O)NCC(=O)N3CCCC3C)c2c1

nearest known ligand 0.64

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PREP P48147 10/20 0.64
FAP Q12884 11/20 0.57
DPP7 Q9UHL4 2/20 0.51
DPP4 P27487 1/20 0.51
DPP9 Q86TI2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26766414 0.93 PREP (0.62) PREPFAPDPP7DPP4DPP9
SCHEMBL26765763 0.91 PREP (0.60) PREPFAPDPP7DPP4DPP9
SCHEMBL26231103 0.90 PREP (0.77) PREPFAPDPP7DPP4DPP9
SCHEMBL30338245 0.88 PREP (0.83) PREPFAPDPP7DPP4DPP9
SCHEMBL25473949 0.88 PREP (0.70) PREPFAPDPP7DPP4DPP9
SCHEMBL25478079 0.88 PREP (0.83) PREPFAPDPP7DPP4DPP9
SCHEMBL26766304 0.88 PREP (0.56) PREPFAPDPP7DPP4DPP9
SCHEMBL26763766 0.83 PREP (0.58) PREPFAPDPP7
SCHEMBL21101376 0.82 PREP (0.74) PREPFAPDPP7
SCHEMBL26223829 0.82 PREP (0.74) PREPFAPDPP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230149569-A1 MULTIFUNCTIONAL COMPOUNDS FOR USE IN MEDICAL IMAGING AND THERAPY ANTELOPE SURGICAL SOLUTIONS, INC. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149569-A1 MULTIFUNCTIONAL COMPOUNDS FOR USE IN MEDICAL IMAGING AND THERAPY PAICS, BID, OGFR PREP 4078/4885FAP 129/4885DPP7 1708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.